# Samsung E&A wins $354M contract to build Sartorius biopharma plant in Songdo

Samsung E&A secured a 518.6 billion-won ($354.2 million) contract to build a biopharmaceutical raw material production and research facility in Songdo, Incheon, for Sartorius AG. The plant will manufacture single-use bioprocessing bags and pharmaceutical membrane filters. Completion is scheduled for 2027.

- Type: Contract
- Announced: 2025-03-24
- Where: Songdo, Incheon, South Korea
- Value: $354.2M
- Status: announced
- Products: single-use bioprocessing bags, pharmaceutical membrane filters
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md), [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Sartorius](https://endata.com/companies/9250.md) (customer)
- [Samsung E&A](https://endata.com/companies/12473.md) (supplier)
- [Sartorius Korea](https://endata.com/companies/83665.md) (customer)

## Sources

- [en.yna.co.kr](https://en.yna.co.kr/view/AEN20250324002300320), 2025-03-24: "Samsung E&A Co. said Monday it has secured a 518.6 billion-won (US$354.2 million) contract to build a biopharmaceutical raw material production and research facility in Songdo."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.